Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $85.4200 (-3.38%) ($84.2040 - $89.4500) on Thu. Feb. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.57% (three month average) | RSI | 52 | Latest Price | $85.4200(-3.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.9% a day on average for past five trading days. | Weekly Trend | ABBV declines -2.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(64%) SPLV(54%) DIA(53%) VYM(53%) IVE(52%) | Factors Impacting ABBV price | ABBV will decline at least -0.785% in a week (0% probabilities). VIXM(-37%) VXX(-14%) TLT(-14%) UUP(-1%) IGOV(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.785% (StdDev 1.57%) | Hourly BBV | -1.3 () | Intraday Trend | -1.3% | | | |
|
Inflection Point | Yes | Resistance Level | $90.49 | 5 Day Moving Average | $90.22(-5.32%) | 10 Day Moving Average | $92.08(-7.23%) | 20 Day Moving Average | $90.49(-5.6%) | To recent high | -12.6% | To recent low | 5.4% | Market Cap | $150.705b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |